Literature DB >> 24090594

Antimicrobial resistance and integrons of commensal Escherichia coli strains from healthy humans in China.

Bin Li, Zhi-Chang Zhao, Mei-Hua Wang, Xin-Hong Huang, Yu-Hong Pan, Ying-Ping Cao.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24090594      PMCID: PMC4014832          DOI: 10.1179/1973947813Y.0000000113

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


× No keyword cloud information.
Antibiotic therapy can affect not only the pathogenic bacteria, but also commensal microorganisms in the gut flora of humans, which might serve as a reservoir of antimicrobial resistance genes.1 Escherichia coli can be found widely in nature, and can also be implicated in human infectious diseases. Therefore, fecal E. coli is often considered as a good indicator for selection pressure imposed by antimicrobial use.2 Recently, many researchers began showing interest in the surveillance of antimicrobial resistance in normal flora of humans.3–5 In China, however, very little is known about the prevalence of antibiotic resistant genes in intestinal tracts of healthy people. The aim of our study is to investigate the prevalence of antimicrobial resistance genes and diversity of integrons in fecal E. coli strains recovered from healthy persons in China. In 2009, we performed a research on the fecal E. coli strains isolated from asymptomatic healthy unrelated human subjects in Fuzhou, China.6 And in this study, 150 fecal E. coli strains were randomly selected from those that were collected in 2009. E. coli ATCC 25922 was used as a positive control. Susceptibility to antibiotics was assessed by the disc diffusion method according to the CLSI.7 The following 18 antimicrobial agents were tested in this study: ampicillin (AMP, 10 μg), ampicillin plus sulbactam (SAM, 10/10 μg), cefazolin (CZO, 30 μg), cefuroxime (CXM, 30 μg), ceftazidime (CAZ, 30 μg), cefotaxime (CTX, 30 μg), cefepime (FEP, 30 μg), cefoxitin (FOX), aztreonam (ATM, 30 μg), imipenem (IPM, 10 μg), amikacin (AMK, 30 μg), kanamycin (KAN, 30 μg), streptomycin (STR, 10 μg), nalidixic acid (NA), ciprofloxacin (CIP, 5 μg), trimethoprim-sulfamethoxazole (SXT, 1.25/23.75 μg), chloramphenicol (CHL, 30 μg), and tetracycline (TET, 30 μg). The discs were obtained from Oxoid Ltd (Basingstoke, Hampshire, England). The presence of genes associated with ampicillin (blaTEM, blaSHV, blaOXA-1), tetracycline (tetA–tetE), streptomycin (aadA), sulphonamide (sul1, sul2 and sul3), kanamycin (aphA1 and aphA2), chloramphenicol resistance (cmlA and floR), and plasmid-borne quinolone resistance genes (qnrA, qnrB, and qnrS) was also analyzed by PCR.8,9 The presence of class 1, 2, and 3 integrons was characterized by PCR in all E. coli strains.8 The characterization of the variable region of class 1 and 2 integrons was performed by PCR and subsequent DNA sequencing. As shown in Table 1, the resistances to STR (79.3%), NA (53.3%), TET (50%), AMP (44%), and SXT (32%) were higher than those of the other antimicrobials (0–19.3%). Of these, streptomycin and tetracycline have been widely used as growth promoters or prophylactic agents in animal husbandry.10 The high resistance of gut flora may be due to the extensive and long-term use of these antibiotics in humans and in livestock. Our study also found that the resistance rate of human fecal E. coli strains to third-generation cephalosporins such as CTX (15.3%) and CAZ (4.0%) was higher than that in other countries.11,12 In China, beta-lactams, aminoglycosides, and quinolones are often used to cure Enterobacteriaceae infections. Therefore, it is not surprising that the high resistance of commensal flora may be due to the extensive use of these antimicrobials.
Table 1

Association between antibiotic profile and integrons in 150 fecal E.coli strains

AntibioticAntibiotic susceptibility
All isolates (n = 150)Integron-positive isolates (n = 40)Integron-negative isolates (n = 110)P-value
% R% I% S% R% I% S% R% I% S
AMP44452652.532.536.44.559.10.006
SAM7.314.77817.52557.53.610.985.50.001
CZO16.744.738.717.547.53516.443.6400.856
CXM140.785.31508513.60.985.50.851
CAZ44922.5592.54.53.691.80.884
CTX15.30.7841508515.50.983.61.000
FEP3.3294.752.592.52.71.895.50.678
FOX1.30.79802.597.51.8098.20.319
ATM40.795.37.5092.52.70.996.40.518
IPM001000010000100
AMK210.787.32.51582.51.89.189.10.480
KAN14.743.3423045259.142.748.20.002
STR79.3200.79010075.523.60.90.116
NA53.33.343.3702.527.547.33.649.10.041
CIP19.3278.727.52.57016.41.881.80.226
SXT3226662.5532.520.90.978.2<0.001
CHL11.3088.732.5067.53.6096.4<0.001
TET501.348.7752.522.540.90.958.2<0.001

Abbreviations:%R, resistant rate;%I, intermediate rate;%S, susceptible rate; n, total number of isolates; AMP, ampicillin; SAM, ampicillin/sulbactam; CZO, Cefazolin; CXM, Cefuroxime; CAZ, ceftazidime; CTX, Cefotaxime; FEP, cefepime; FOX, cefoxitin; ATM, aztreonam; IPM, imipenem; AMK, amikacin; KAN, kanamycin; STR, streptomycin; NA, nalidixic acid; CIP, ciprofloxacin; SXT, trimethoprim-sulfamethoxazole; CHL, chloramphenicol; TET, tetracycline.

Abbreviations:%R, resistant rate;%I, intermediate rate;%S, susceptible rate; n, total number of isolates; AMP, ampicillin; SAM, ampicillin/sulbactam; CZO, Cefazolin; CXM, Cefuroxime; CAZ, ceftazidime; CTX, Cefotaxime; FEP, cefepime; FOX, cefoxitin; ATM, aztreonam; IPM, imipenem; AMK, amikacin; KAN, kanamycin; STR, streptomycin; NA, nalidixic acid; CIP, ciprofloxacin; SXT, trimethoprim-sulfamethoxazole; CHL, chloramphenicol; TET, tetracycline. Of the 150 E. coli strains tested, 40 (26.7%) carried integrons, among which 39 (97.5%) carried intI1 and only 1 strain carried intI2. Class 3 integrons were not detected in the study. The prevalence of the integrase gene (26.7%) in this study was similar to that in Spain (29%),11 however, it is lower than that found in clinical Enterobacteriaceae isolates in China (59.9%).13 All integron-positive strains showed resistance to at least three antimicrobial agents, as found in previous studies.11,13,14 Six different gene cassette arrangements were demonstrated in 24 of the 39 intI1-positive isolates and were as follows (number of isolates): dfrA17-aadA5 (8), aadA1(6), aadA2(4), aadA5(2), dfrA5(2), and dfrA7(2). Only one E. coli isolate in this study containing class 2 integrons presented the gene cassette array in its variable region: dfrA1- sat2- aadA1, also being frequent in other study.8 And the most frequently detected resistance genes (aadA family and dfr family) in this study were aminoglycoside adenylyltransferase genes and dihydrofolate reductase genes that confer resistance to streptomycin, spectinomycin, and trimethoprim. The high frequencies of aadA and dfr family detection in integrons are similar to other studies.11,13,14 Integrons were significantly associated with AMP, SAM, SXT, KAN, NA, CHL, and TET (Table 1), and all 40 integron-positive isolates showed resistance to at least three antimicrobial agents. Higher percentages of resistance to some antimicrobial agents (STR, AMP, TET, SXT, CHL, and NA) were observed among integron-positive isolates with respect to integron-negative isolates. Table 2 shows the antimicrobial resistance genes detected in our isolates. The blaTEM gene was detected in 27 of the 74 ampicillin-resistant isolates and the blaOXA-1 gene in one additional isolate. Regarding tetracycline resistance, the tetA gene was the predominant one in those strains, and it has been previously suggested that tetA gene and class 1 integrons are often located on the same conjugative plasmid.15
Table 2

Genes of resistance detected among commensal E. coli strains with and without integrons

AntibioticsIntegron-positive strains (n = 40)Integron-negative strains (n = 110)
numberGenes detected (no. of strains)numberGenes detected (no. of strains)
ampicillin27blaTEM (12)45blaTEM (15)
blaOXA-1 (1)
tetracycline31tetA (5)46tetA (10)
tetB (5)tetB (7)
tetA+tetB (1)
sulponamide27sul-1 (3)24sul-1 (7)
sul-2 (1)sul-1+ sul-2 (5)
sul-1+ sul-2 (8)
sul-2+ sul-3 (1)
nalidixic acid29qnrS (1)55NDa
streptomycin33aadA (8)61NDa
kanamycin19aphA1 (7)31aphA1 (1)
chloramphenicol13cmlA1 (6)4cmlA1 (2)
floR (2)floR (1)

a ND, no gene detected.

a ND, no gene detected. Higher percentage of resistance to some antimicrobial agents (aminoglycoside, sulphanilamides, quinolones, and beta-lactam agents) were observed among integron-positive strains with respect to integron-negative strains (Table 1). The fact could be explained by the presence of resistance genes in the conserved or variable region of integrons, or by the inclusion of resistance genes in the same mobile elements that carry integrons.11 The following genes were identified among 51 SXT-resistant isolates (integron-positive/integron-negative isolates): sul1 (3/7), sul2 (1/0), sul1+sul2 (8/0) and sul2+sul3 (1/0). The aphA1 gene was found in 8 of 50 kanamycin-resistant E. coli isolates. Among the 17 chloramphenicol-resistant E. coli isolates, the cmlA and floR genes were found in eight and three isolates, respectively. Among the 29 nalidixie acid-resistant integron-positive isolates, the qnrS gene was found in one isolate. And aadA gene was detected in 8 of 33 streptomycin resistant integron-positive isolates. In conclusion, this study demonstrates that multidrug resistance genes and integrons are widespread in fecal E. coli strains from healthy people in China. The integrons may contribute to the dissemination of antibiotic resistance in the gut flora. The data of this study provides useful information regarding the dissemination of antibiotic resistance among healthy humans in the community. Continued surveillance of normal flora should be carried out to predicting the antimicrobial resistance trends of clinical Enterobacteriaceae isolates in this region.
  14 in total

1.  Reservoirs of antibiotic resistance genes.

Authors:  Abigail Salyers; Nadja B Shoemaker
Journal:  Anim Biotechnol       Date:  2006       Impact factor: 2.282

2.  Identification of the plasmid-borne quinolone resistance gene qnrS in Salmonella enterica serovar Infantis.

Authors:  Corinna Kehrenberg; Sonja Friederichs; Anno de Jong; Geovana Brenner Michael; Stefan Schwarz
Journal:  J Antimicrob Chemother       Date:  2006-05-23       Impact factor: 5.790

3.  Characterization of antimicrobial resistance and class 1 integrons found in Escherichia coli isolates from humans and animals in Korea.

Authors:  Hee Young Kang; Young Sook Jeong; Jae Young Oh; Sung Ho Tae; Chul Hee Choi; Dong Chan Moon; Won Kil Lee; Yoo Chul Lee; Sung Yong Seol; Dong Taek Cho; Je Chul Lee
Journal:  J Antimicrob Chemother       Date:  2005-03-10       Impact factor: 5.790

4.  Phylogenetic groups and pathogenicity island markers in fecal Escherichia coli isolates from asymptomatic humans in China.

Authors:  Bin Li; Jing-yong Sun; Li-zhong Han; Xin-hong Huang; Qiang Fu; Yu-xing Ni
Journal:  Appl Environ Microbiol       Date:  2010-08-13       Impact factor: 4.792

5.  High prevalence of antibiotic resistance in commensal Escherichia coli among children in rural Vietnam.

Authors:  Oliver James Dyar; Nguyen Quynh Hoa; Nguyen V Trung; Ho D Phuc; Mattias Larsson; Nguyen T K Chuc; Cecilia Stålsby Lundborg
Journal:  BMC Infect Dis       Date:  2012-04-18       Impact factor: 3.090

6.  Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal, and food origins.

Authors:  Yolanda Sáenz; Laura Briñas; Elena Domínguez; Joaquim Ruiz; Myriam Zarazaga; Jordi Vila; Carmen Torres
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

7.  Prevalence and diversity of integrons and associated resistance genes in faecal Escherichia coli isolates of healthy humans in Spain.

Authors:  Laura Vinué; Yolanda Sáenz; Sergio Somalo; Esther Escudero; Miguel Angel Moreno; Fernanda Ruiz-Larrea; Carmen Torres
Journal:  J Antimicrob Chemother       Date:  2008-08-15       Impact factor: 5.790

8.  Genetic characterization of antibiotic resistance genes linked to class 1 and class 2 integrons in commensal strains of Escherichia coli isolated from poultry and swine.

Authors:  Lisette Lapierre; Javiera Cornejo; Consuelo Borie; Cecilia Toro; Betty San Martín
Journal:  Microb Drug Resist       Date:  2008-12       Impact factor: 3.431

9.  Global spread of mobile antimicrobial drug resistance determinants in human and animal Escherichia coli and Salmonella strains causing community-acquired infections.

Authors:  Remi M Ajiboye; Owen D Solberg; Bryan M Lee; Eva Raphael; Chitrita Debroy; Lee W Riley
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079

Review 10.  Commensals upon us.

Authors:  M N Alekshun; S B Levy
Journal:  Biochem Pharmacol       Date:  2006-02-07       Impact factor: 5.858

View more
  8 in total

1.  Tetracycline-Resistant Genes in Escherichia coli from Clinical and Nonclinical Sources in Rivers State, Nigeria.

Authors:  Doubra Otis Perewari; Kome Otokunefor; Obakpororo Ejiro Agbagwa
Journal:  Int J Microbiol       Date:  2022-07-09

2.  Probable secondary transmission of antimicrobial-resistant Escherichia coli between people living with and without pets.

Authors:  Yeon Soo Chung; Young Kyung Park; Yong Ho Park; Kun Taek Park
Journal:  J Vet Med Sci       Date:  2017-02-11       Impact factor: 1.267

3.  Comparison of Commensal Escherichia coli Isolates from Adults and Young Children in Lubuskie Province, Poland: Virulence Potential, Phylogeny and Antimicrobial Resistance.

Authors:  Ewa Bok; Justyna Mazurek; Andrzej Myc; Michał Stosik; Magdalena Wojciech; Katarzyna Baldy-Chudzik
Journal:  Int J Environ Res Public Health       Date:  2018-03-28       Impact factor: 3.390

4.  Relationships between Virulence Factors and Antimicrobial Resistance among Escherichia coli Isolated from Urinary Tract Infections and Commensal Isolates in Tehran, Iran.

Authors:  Mohammad Reza Asadi Karam; Mehri Habibi; Saeid Bouzari
Journal:  Osong Public Health Res Perspect       Date:  2018-10

5.  The Resistance Patterns in E. coli Isolates among Apparently Healthy Adults and Local Drivers of Antimicrobial Resistance: A Mixed-Methods Study in a Suburban Area of Nepal.

Authors:  Abha Shrestha; Rajeev Shrestha; Pramesh Koju; Sudichhya Tamrakar; Anisha Rai; Priyanka Shrestha; Surendra Kumar Madhup; Nishan Katuwal; Archana Shrestha; Akina Shrestha; Sunaina Shrestha; Sandip K C; Supriya Kharel; Pooja Tamang; Pruthu Thekkur; Sony Shakya Shrestha
Journal:  Trop Med Infect Dis       Date:  2022-07-12

Review 6.  Escherichia coli β-Lactamases: What Really Matters.

Authors:  Priyanka Bajaj; Nambram S Singh; Jugsharan S Virdi
Journal:  Front Microbiol       Date:  2016-03-30       Impact factor: 5.640

7.  Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance.

Authors:  Chhaya Shah; Ratna Baral; Bijay Bartaula; Lok Bahadur Shrestha
Journal:  BMC Microbiol       Date:  2019-09-02       Impact factor: 3.605

8.  Characterization of Integrons and Antimicrobial Resistance in Escherichia coli Sequence Type 131 Isolates.

Authors:  Jiangqing Huang; Fangjun Lan; Yanfang Lu; Bin Li
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-02-24       Impact factor: 2.471

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.